| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -24,500 | -100.0% | -0.03% | – |
| TCMD | Exit | TACTILE SYSTEMS TECHNOLOGY I | $0 | – | -27,100 | -100.0% | -0.04% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -656,200 | -100.0% | -0.07% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -160,800 | -100.0% | -0.10% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -278,985 | -100.0% | -0.11% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -166,069 | -100.0% | -0.14% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -64,700 | -100.0% | -0.19% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -732,400 | -100.0% | -0.21% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -111,717 | -100.0% | -0.31% | – |
| GOSS | Exit | GOSSAMER BIO INC | $0 | – | -6,530,288 | -100.0% | -0.52% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -472,600 | -100.0% | -0.65% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -386,832 | -100.0% | -0.70% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -5,675,876 | -100.0% | -0.72% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -431,224 | -100.0% | -0.73% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -660,275 | -100.0% | -1.01% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -94,030 | -100.0% | -1.08% | – |
| ALKS | Exit | ALKERMES PLC | $0 | – | -603,400 | -100.0% | -1.60% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -55,705 | -100.0% | -1.61% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -2,739,379 | -100.0% | -1.92% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -1,005,776 | -100.0% | -1.96% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -2,405,793 | -100.0% | -4.74% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -1,374,822 | -100.0% | -5.23% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -5,228,609 | -100.0% | -5.67% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -1,657,458 | -100.0% | -7.57% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -381,282 | -100.0% | -9.27% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -10,524,022 | -100.0% | -12.11% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP | $0 | – | -575,907 | -100.0% | -12.31% | – |
| INSM | Exit | INSMED INC | $0 | – | -5,889,491 | -100.0% | -14.07% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -1,831,035 | -100.0% | -15.33% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Biomarin Pharmaceuticals, Inc | 42 | Q3 2023 | 16.6% |
| UNITED THERAPEUTICS CORP DEL | 42 | Q3 2023 | 15.3% |
| INSMED INC | 42 | Q3 2023 | 14.1% |
| STAAR Surgical Company | 42 | Q3 2023 | 11.8% |
| AMICUS THERAPEUTICS INC | 42 | Q3 2023 | 12.1% |
| VANDA PHARMACEUTICALS INC | 42 | Q3 2023 | 5.8% |
| PROTHENA CORP PLC | 42 | Q3 2023 | 9.1% |
| CYTOKINETICS INC | 40 | Q3 2023 | 0.4% |
| ALIGN TECHNOLOGY INC | 39 | Q3 2023 | 2.5% |
| ABIOMED INC | 38 | Q3 2022 | 17.1% |
View Palo Alto Investors LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ALIMERA SCIENCES INCSold out | April 03, 2023 | 0 | 0.0% |
| Epizyme, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| INSMED Inc | February 14, 2023 | 5,871,291 | 4.3% |
| Vanda Pharmaceuticals Inc. | February 14, 2023 | 1,087,064 | 1.4% |
| ALIMERA SCIENCES INC | February 14, 2022 | 802,423 | 11.6% |
| Clovis Oncology, Inc. | February 14, 2022 | 3,997,826 | 3.1% |
| STAAR SURGICAL CO | February 14, 2022 | 1,140,511 | 2.4% |
| Aimmune Therapeutics, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| AMAG PHARMACEUTICALS, INC.Sold out | February 16, 2021 | 0 | 0.0% |
| ALIMERA SCIENCES INC | February 14, 2020 | 802,424 | 16.2% |
View Palo Alto Investors LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-04-03 |
| 4 | 2023-03-28 |
View Palo Alto Investors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.